Ditchcarbon
  • Contact
  1. Organizations
  2. SeqLL Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

SeqLL Inc. Sustainability Profile

Company website

SeqLL Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in advanced genomic sequencing technologies. Founded in 2017, SeqLL has rapidly established itself as a leader in the field, focusing on innovative solutions that enhance the accuracy and efficiency of DNA and RNA sequencing. The company’s flagship products, including the SeqLL platform, are distinguished by their unique ability to provide high-throughput, cost-effective sequencing with unparalleled precision. This positions SeqLL at the forefront of genomic research and personalised medicine, catering to a diverse clientele that includes academic institutions, pharmaceutical companies, and healthcare providers. With a commitment to advancing genomic science, SeqLL Inc. continues to achieve significant milestones, solidifying its reputation as a trusted partner in the life sciences industry.

DitchCarbon Score

How does SeqLL Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

SeqLL Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

28%

Let us know if this data was useful to you

SeqLL Inc.'s reported carbon emissions

SeqLL Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company is classified as a merged entity, and any potential emissions data or climate commitments may be inherited from its corporate family. However, no specific information regarding emissions or climate initiatives has been provided. As a merged entity, SeqLL Inc. may align its climate strategies with broader industry standards, but without concrete data or commitments, it is challenging to assess its current environmental impact or future goals. The absence of reported emissions and reduction targets suggests that SeqLL Inc. is in the early stages of developing its climate strategy or may rely on overarching commitments from its parent organisation.

How Carbon Intensive is SeqLL Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. SeqLL Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is SeqLL Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for SeqLL Inc. is in US, which has a low grid carbon intensity relative to other regions.

SeqLL Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

SeqLL Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare SeqLL Inc.'s Emissions with Industry Peers

Intrexon Bioinformatics Germany GmbH

DE
•
Computer and related services (72)
Updated about 1 month ago

Pacific Biosciences of California, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Zymergen Inc.

US
•
Electrical machinery and apparatus n.e.c. (31)
Updated 25 days ago

Ultima Genomics, Inc.

US
•
Research and development services (73)
Updated 6 days ago

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 18 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy